Ibm Retirement Fund Repligen Corp Transaction History

Ibm Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$161.19 - $257.96 $146,844 - $235,001	-911 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$247.59 - $304.47 $157,467 - $193,642	-636 Reduced 41.11%	911 $241,000
Q2 2021 Jul 12, 2021	SELL	$165.87 - $220.95 $44,453 - $59,214	-268 Reduced 14.77%	1,547 $309,000
Q1 2021 Apr 22, 2021	SELL	$180.37 - $226.26 $24,169 - $30,318	-134 Reduced 6.88%	1,815 $353,000
Q4 2020 Jan 25, 2021	BUY	$148.08 - $206.57 $37,316 - $52,055	252 Added 14.85%	1,949 $373,000
Q3 2020 Oct 16, 2020	BUY	$122.51 - $158.27 $207,899 - $268,584	1,697 New	1,697 $250,000

490

53.8M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.69B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.